European Academy of Dermatology & Venereology - EADV
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Academy of Dermatology & Venereology - EADV — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
European Academy of Dermatology & Venereology (EADV) — EADV Congress 2026
The EADV Congress 2026 is Europe’s leading congress focused on skin and sexual health, bringing together an international community of specialists, researchers, and industry stakeholders to share scientific advances and strengthen collaboration across the dermatology and venereology ecosystem.
Dates: 30 September – 3 October 2026
Location: Vienna, Austria
What the Congress is About
EADV Congress 2026 is designed as a hub for scientific exchange, collaboration, and community within the dermatology and venereology fields. The programme is built around the latest knowledge, research developments, and practical learning opportunities for attendees.
Scientific Programme & Learning Format
The congress includes a structured scientific programme featuring activities such as:
- Scientific sessions focused on current research and developments
- Abstracts presented as part of the scientific content
- Workshops to support deeper practical engagement
- CME-CPD and associated certificates
- Late-breaking abstracts to capture emerging developments
- Subspecialties spanning multiple areas of dermatology and venereology
Who Comes to the Event
The congress attracts a broad dermatology and venereology community, including healthcare professionals and researchers who are actively engaged in advancing patient care and clinical research. It also supports participation from the wider professional network connected to dermatology and sexual health.
Scale and Reach
The congress is expected to be a large international gathering. The event highlights that it brought together over 20,000 delegates in 2025, reaffirming its position as a leading platform for knowledge sharing and cross-community engagement.
Industry Participation
The congress provides industry opportunities through its dedicated industry participation pathway. Industry applications open so companies can register and access relevant information about how to take part, including exhibition and sessions (as described on the congress pages).
Registration and Member-Related Opportunities
Registration is available through the congress platform, and the congress notes several member-focused features and participation options. These include:
- Workshops with registration opening on 1 June and priority given to EADV Members
- Social media reporters participation to shape how the event is experienced by a global audience
- Reduced registration fee opportunities for a limited number of attendees (noted as 500 attendees eligible for discounted access)
- HCP scholarship support for trainees or specialists under 45 years of age
- Early bird fee availability before 15 April 2026
- Abstract submission details and deadlines supported through congress communications (with at least one “deadline extended” update indicated on the site)
Sustainability and Community Services
EADV Congress 2026 also emphasizes sustainability and provides additional services for attendees. The congress page references:
- Sustainability in action as an ongoing commitment for the event
- Accommodation supported via an official hotel accommodation platform
- On-site childcare provided through an on-site professional childcare service (as noted on the congress page)
- Patient organisations support through a patient online portal and a request process for participation in the patient organisations area
Event Positioning for Buyers and Partners
For organizations looking to engage with the dermatology and venereology community, EADV Congress 2026 offers a concentrated platform where medical expertise, research advancement, and professional collaboration intersect. The event’s international profile in Vienna during 30 Sep – 3 Oct 2026 makes it a strong networking and engagement venue for relevant stakeholders in the skin and sexual health space.
Data sheet
European Academy of Dermatology & Venereology - EADV – Event Attendee & Buyer Profile Analysis
Event date: 30 Sep 2026 - 3 Oct 2026
Location: Vienna, Austria
Event status: Upcoming
Research date: 1 July 2026
Event Overview
| Field | Details |
|---|---|
| Event Name | European Academy of Dermatology & Venereology - EADV Congress 2026 |
| Event Date | 30 Sep 2026 - 3 Oct 2026 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official text |
| City | Vienna |
| State / Region | Vienna |
| Country | Austria |
| Organizer | European Academy of Dermatology and Venereology (EADV) |
| Official Event Website | eadv.org/congress/ |
| Event Type | International medical congress / scientific conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. Historical evidence: over 20,000 delegates in 2025. |
| Attendance Data Reliability | Medium for historical reference; low for 2026 until organizer publishes final figures |
| Main Purpose of Event | To convene dermatology and venereology professionals for scientific exchange, clinical education, research updates, networking, and industry engagement |
About the Event
EADV Congress is Europe’s leading congress on skin and sexual health, bringing together dermatology and venereology specialists, researchers, trainees, patient organizations, and industry partners. The official 2026 congress page confirms Vienna as the host city and positions the event as a major scientific meeting with education, abstracts, workshops, exhibition, and industry participation streams.
This event matters because it concentrates decision-makers and influencers across clinical practice, research, product evaluation, and medical education. For suppliers to the dermatology ecosystem, it is a strong venue for lead generation, partnership development, medical device and pharmaceutical outreach, clinical innovation positioning, and engagement with specialist healthcare buyers across Europe and beyond.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Dermatologists and venereologists | Hospitals, private clinics, academic medical centers, specialty practices | Clinical decision-makers and product evaluators | Core audience for therapies, diagnostics, devices, and practice solutions |
| Hospital procurement and pharmacy teams | Public and private hospitals, health systems | Purchasing, formulary, and supply chain influence | Relevant for medical products, consumables, and service contracts |
| Practice owners and clinic directors | Private dermatology and aesthetic clinics | Budget owners and purchasing approvers | High relevance for equipment, software, and patient management tools |
| Researchers and trial investigators | Universities, research institutes, CRO-linked teams | Protocol advisors and study collaborators | Important for clinical research services, diagnostics, and trial support |
| Medical affairs and market access teams | Pharmaceutical and biotech companies | Scientific engagement and evidence generation | Relevant for drugs, biologics, and medical education providers |
| Product and brand managers | Pharma, medtech, skincare, diagnostics | Go-to-market and product strategy | Useful for launch planning, KOL outreach, and market intelligence |
| Association and society leaders | Medical associations, specialty societies | Program and partnership influence | Relevant for sponsorships, education partnerships, and advocacy support |
| Patient organization representatives | Skin disease advocacy and support groups | Advocacy and awareness influence | Relevant for patient support programs and education content |
| Industry exhibitors and sponsors | Pharma, device, diagnostics, digital health, skincare | Commercial investment and partnership decision-makers | Key for business development, sponsorship, and competitive intelligence |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Vienna host city | Local hospital systems, universities, clinics, associations | Medium | Strong local turnout expected for logistics, networking, and educational access |
| Austria / surrounding region | Healthcare buyers from Austria, Central Europe, and neighboring markets | High | Vienna is well positioned for DACH and CEE participation |
| European Union and EEA | Specialist physicians, researchers, pharma teams, society leaders | Very High | EADV is a pan-European scientific congress with broad regional draw |
| United Kingdom, Switzerland, Nordics | Specialists, industry delegates, research stakeholders | Medium to High | Important for premium clinical, research, and biotech targeting |
| Global long-haul markets | International dermatology leaders, global pharma, patient orgs | Medium | Likely international reach due to scientific reputation and industry participation |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The congress serves an international specialist audience and is positioned as Europe’s leading dermatology and venereology meeting. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Pfizer | Pharma buyer | Dermatology and immunology commercialization, medical affairs, and scientific exchange | pfizer.com | Medical Affairs Director, Brand Director, Market Access Manager | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharma buyer | Strong dermatology portfolio relevance and KOL engagement needs | abbvie.com | Medical Affairs Lead, Product Manager, Commercial Director | Strong Market Fit, Attendance Not Confirmed |
| Sanofi | Pharma buyer | Skin immunology, biologics, and medical education relevance | sanofi.com | Medical Affairs, Brand Lead, External Affairs | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharma buyer | Dermatology, immunology, and healthcare professional engagement | novartis.com | Scientific Lead, Marketing Director, HEOR Lead | Strong Market Fit, Attendance Not Confirmed |
| Roche | Diagnostics / pharma buyer | Clinical diagnostics, research partnerships, and specialty care programs | roche.com | Diagnostics Lead, Scientific Affairs Manager, Partnership Director | Strong Market Fit, Attendance Not Confirmed |
| Leo Pharma | Dermatology pharma buyer | Direct dermatology specialization makes this a high-fit target | leopharma.com | Country Manager, Medical Affairs Manager, Field Medical Lead | Strong Market Fit, Attendance Not Confirmed |
| UCB | Biopharma buyer | Immunology and specialty care stakeholder with relevant medical education needs | ucb.com | Medical Advisor, Brand Manager, Market Access Director | Strong Market Fit, Attendance Not Confirmed |
| L'Oréal Dermatological Beauty | Skincare buyer | Medical skincare and dermatology-adjacent commercial activity | loreal.com | Category Manager, Medical Relations Lead, Marketing Director | Strong Market Fit, Attendance Not Confirmed |
| Charité - Universitätsmedizin Berlin | Academic hospital | Major research and clinical center likely to send specialist attendees | charite.de | Department Head, Professor, Research Coordinator | Strong Market Fit, Attendance Not Confirmed |
| Klinikum rechts der Isar, TUM | Academic medical center | Dermatology research and specialist clinical practice buyer profile | tum.de | Clinic Director, Consultant Dermatologist, Research Lead | Strong Market Fit, Attendance Not Confirmed |
| U.S. Food and Drug Administration | Government regulator | Regulatory and clinical evidence stakeholders relevant to the medical product ecosystem | fda.gov | Regulatory Affairs Lead, Policy Advisor, Scientific Reviewer | Strong Market Fit, Attendance Not Confirmed |
| NHS England | Public healthcare buyer | Large-scale health system with procurement and clinical pathway influence | england.nhs.uk | Clinical Lead, Procurement Manager, Service Improvement Lead | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Healthcare provider | High-value clinical decision-making and research collaboration profile | mayoclinic.org | Department Chair, Physician Lead, Research Director | Strong Market Fit, Attendance Not Confirmed |
| Apollo Hospitals | Healthcare network | Large clinical network with dermatology service and procurement needs | apollohospitals.com | Medical Director, Procurement Head, Specialty Care Lead | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Dermatologist / Consultant Dermatologist | Clinical | Senior / Specialist | Primary end-user and clinical evaluator for therapies, devices, and practice tools |
| 2 | Medical Affairs Director | Medical Affairs | Director | Engages scientific leaders and shapes evidence communication |
| 3 | Brand Director / Product Manager | Commercial | Manager / Director | Owns launch planning, positioning, and congress activation |
| 4 | Market Access Lead | Market Access / HEOR | Manager / Director | Interested in value evidence, reimbursement, and payer-facing messaging |
| 5 | Clinic Director / Practice Owner | Operations | Owner / Director | Controls budget for equipment, software, staffing, and patient experience |
| 6 | Research Director / Principal Investigator | R&D | Senior | Relevant for trials, studies, collaborative research, and data platforms |
| 7 | Procurement Manager | Procurement / Supply Chain | Manager | Buys consumables, devices, services, and facility-related products |
| 8 | Clinical Operations Director | Operations | Director | Influences workflow, patient throughput, and vendor selection |
| 9 | Association Executive / Society Officer | Leadership | Executive | Important for sponsorships, partnerships, and educational programming |
| 10 | Regulatory Affairs Manager | Regulatory | Manager / Senior Manager | Supports compliance for medical products and scientific claims |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core commercial and scientific audience for dermatology therapies | Medical affairs, brand teams, evidence generation |
| 2 | Biotechnology | Innovation-heavy skin disease treatment and research stakeholders | R&D, clinical trials, partnership development |
| 3 | Medical Devices | Relevant for dermatology tools, lasers, imaging, and treatment systems | Device commercialization and clinical adoption |
| 4 | Hospital & Health Care | Hospitals and health systems represent high-value clinical buyers | Procurement, service lines, specialist departments |
| 5 | Research | Academic and clinical research is central to this congress | Study collaborations, grants, data tools |
| 6 | Information Technology & Services | Digital health, practice software, CRM, telemedicine, and analytics | Clinic operations and patient engagement solutions |
| 7 | Health, Wellness & Fitness | Skincare, patient wellness, and specialty care overlap | Consumer-facing education and care programs |
| 8 | Government Administration | Public health agencies and regulator stakeholders may attend or engage | Policy, public health, reimbursement, clinical standards |
| 9 | Medical Practice | Private specialist practices are a major attendee base | Practice management, devices, consumables |
| 10 | Events Services | Sponsors, association partners, and congress support vendors | Exhibition services, congress operations, sponsorship sales |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Organizer has not published a 2026 final figure in the provided text | Use historical and post-event data when released |
| Historical attendance | Over 20,000 delegates | Historical / prior-year evidence | Official event website text referencing 2025 | Useful for directional sizing only |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified count in provided official text | Check exhibitor prospectus or floorplan when available |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer breakdown published in provided text | Likely embedded within delegate mix |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda and abstract programming are referenced, but no count provided | Potentially material for KOL mapping when agenda is released |
| Sponsor count | Not publicly confirmed | Unconfirmed | Industry participation is referenced, but no count provided | Use official sponsorship pages for validation |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical innovation | New treatments, techniques, and evidence-based updates | Scientific symposia, KOL meetings, data presentations | Therapies, diagnostics, clinical evidence platforms |
| Medical education | CME/CPD, skills workshops, subspecialty learning | Education sponsorships and faculty partnerships | Training content, learning platforms, events support |
| Research and abstracts | Publication exposure and collaborative science | Abstract booth outreach, investigator meetings, poster sessions | Research services, data capture tools, CRO support |
| Patient engagement | Disease awareness and patient support | Patient organization area, education content, advocacy meetings | Patient support programs, communication tools |
| Industry participation | Brand visibility and commercial networking | Exhibition, sponsorship, sponsored sessions | Commercial exhibits, meeting solutions, congress services |
| Sustainability and event operations | Lower-impact congress delivery and attendee services | Operational partnerships and sustainable event procurement | Event logistics, eco-friendly supplies, digital tools |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The congress draws specialist clinicians, healthcare organizations, and industry stakeholders with meaningful buying influence. |
| Decision-maker availability | High | Senior physicians, medical affairs leaders, and practice owners are likely to be present. |
| Data collection potential | Medium | Strong if official exhibitor, agenda, speaker, or abstract lists are published; weaker if relying only on general congress information. |
| Apollo targeting potential | Very High | Clear targeting pathways exist across pharma, medtech, hospitals, research, and healthcare networks. |
| Geographic targeting potential | High | Vienna supports strong EU and CEE targeting, while the congress also attracts broader international stakeholders. |
| Best outreach approach | High-touch, scientific, and account-based | Use KOL-informed outreach, congress-triggered messaging, and role-based segmentation. |
| Overall lead quality | Very High | A strong B2B attendee list-building event for healthcare, pharma, device, and research targeting. |
| Best use case | Lead generation and account mapping | Ideal for attendee list sales, exhibitor prospecting, clinical outreach, and partnership development. |
| Limitations / risks | Moderate | 2026 attendance, exhibitor, and speaker details were not fully published in the provided source text at time of research. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Hospital & Health Care; Research; Medical Practice; Information Technology & Services; Health, Wellness & Fitness | Prioritize the most relevant buyer ecosystems for this congress |
| Departments | Medical Affairs; Clinical; R&D; Procurement; Supply Chain; Marketing; Commercial; Market Access; Operations; Partnerships | Reach both clinical influencers and commercial buyers |
| Seniority | Manager; Senior Manager; Director; VP; CXO; Owner; Partner; Professor; Department Head | Prioritize decision-makers and scientific leaders |
| Job titles | Dermatologist; Consultant Dermatologist; Medical Affairs Director; Brand Director; Product Manager; Procurement Manager; Research Director; Clinic Director; Practice Owner; Market Access Lead; Clinical Operations Director | High relevance to purchasing and influence roles |
| Geography | Austria; Germany; Switzerland; United Kingdom; France; Italy; Spain; Benelux; Nordics; Central and Eastern Europe | Reflects expected European draw with global spillover |
| Employee size | 11-50; 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001+ | Covers specialist practices, hospitals, and enterprise pharma/medtech accounts |
| Keywords | dermatology, venereology, immunology, skin health, psoriasis, atopic dermatitis, eczema, clinical research, medical affairs, biologics, aesthetics, patient support | Refine to congress-relevant specialty and commercial signals |
| Company type | Public companies; private companies; hospitals; clinics; universities; nonprofit associations | Expand coverage across buyer and influence organizations |
Suggested Apollo Search Logic: (dermatology OR venereology OR skin health OR immunology OR biologics OR psoriasis OR eczema) AND (Medical Affairs OR Clinical OR Procurement OR Research OR Market Access OR Clinic Director OR Practice Owner OR Product Manager) AND geography: Europe / Austria / DACH / UK / France / Italy / Spain.
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| EADV Congress 2026 official page | Official organizer source | Event name, dates, host city, congress positioning, member/industry pages, and historical delegate reference | Very High |
| EADV official website | Official organizer source | Organizer identity, congress ecosystem, scientific and industry navigation, and institutional positioning | Very High |
| Provided official website text | Primary source excerpt | Verified that Vienna is the host city and 30 Sep - 3 Oct 2026 are the congress dates; also confirmed historical 2025 delegate reference | Very High |
| Official website content provided in prompt | Primary source excerpt | Confirmed congress theme, industry participation pathway, registration messaging, workshops, abstracts, and patient organization references | Very High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Academy of Dermatology & Venereology - EADV — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds